title: Ventricular assist devices: The future is now.
abstract: Heart failure has become a global epidemic. For advanced heart failure, a broad assortment of device options have been introduced for both acute and prolonged intervals of hemodynamic assistance. Durable implantable ventricular assist devices (VADs) in particular play a key role in the management of advanced heart failure. This review focuses specifically on the current outcomes with VAD therapy, highlights the results from pivotal clinical trials, and summarizes the various device options on the market and those in preclinical development.
authors.affiliation: Department of Cardiac Surgery, Baylor University Medical Center, Dallas, TX.
authors.forename: Brian
authors.initials: B
authors.lastname: Lima
authors.affiliation: Department of Cardiac Surgery, The Heart Hospital, Baylor Plano, Plano, TX.
authors.forename: Michael
authors.initials: M
authors.lastname: Mack
authors.affiliation: Department of Cardiac Surgery, Baylor University Medical Center, Dallas, TX. Electronic address: gonzo.gonzalez@baylorhealth.edu.
authors.forename: Gonzalo V
authors.initials: GV
authors.lastname: Gonzalez-Stawinski
mesh_terms: D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000401:mortality / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects / Q000639:trends*; D006801:Humans; D018579:Patient Selection; D011474:Prosthesis Design / Q000639:trends; D011788:Quality of Life; D016019:Survival Analysis; D016896:Treatment Outcome